The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA issues clearance for new IPL device

Article-FDA issues clearance for new IPL device

Wayland, Mass. — The Ellipse™ Flex IPL (intense pulsed light) system, developed by Wayland-based Candela Corp., has earned clearance from the Food and Drug Administration.

According to Candela, the Ellipse Flex IPL was developed in cooperation with dermatologists and skin researchers. The device is intended for various cosmetic treatments and applications, such as facial rejuvenation, vascular lesions, facial veins, acne, age spots and diffuse redness.

The company says the Ellipse Flex IPL features a programmable pulse mode, which allows the user to “customize” pulse output to each individual patient’s particular clinical needs. The device also includes “Dual-Mode Filtering” technology, a patented feature that removes potentially harmful water-absorbing wavelengths from the output spectrum. This technology, according to Candela, decreases the risk of side effects.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.